Recent Finacing
Recent Raise
C2N Diagnostics is a clinical laboratory providing mass spectrometry–based brain-health biomarker assays (e.g., Precivity) for Alzheimer’s research, clinical decision-making, treatment monitoring, and global testing partnerships.
Recent Investors
Total Raised
Funding round
Investor
